We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ARDS market cap is 12.88M. The company's latest EPS is USD -0.6814 and P/E is -0.10.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 399k | 1.21M | 1.08M | 19.65M | 417k |
| Operating Income | -7.41M | -7.42M | -6.26M | 13.67M | -869k |
| Net Income | -8.24M | -6.39M | -6.82M | 12.14M | -83k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.76M | 1.02M | 1M | 1.54M | 3.09M |
| Operating Income | -24.16M | -30.04M | -22.41M | -42.71M | -29.99M |
| Net Income | -23.46M | -29.68M | -22.33M | -46.32M | -30.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.12M | 14.7M | 9.43M | 6.48M | 6.53M |
| Total Liabilities | 47.94M | 38.93M | 37.32M | 21.4M | 18.34M |
| Total Equity | -35.82M | -24.23M | -27.88M | -14.91M | -11.8M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.61M | 27.97M | 15.12M | 26.8M | 14.7M |
| Total Liabilities | 5.3M | 24.33M | 23.8M | 39.91M | 38.93M |
| Total Equity | 26.31M | 3.64M | -8.68M | -13.11M | -24.23M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.57M | -29.13M | -4M | -8.35M | -9.33M |
| Investing | -33k | -82k | N/A | 14k | 14k |
| Financing | 3.75M | 14.78M | 263k | 3.29M | 4.29M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.27M | -8.16M | -20.48M | -22.94M | -29.13M |
| Investing | -1.68M | -174k | -367k | -530k | -82k |
| Financing | 25.09M | 4.99M | 8.68M | 34.72M | 14.78M |
| Market Cap | 12.88M |
| Price to Earnings Ratio | -0.10 |
| Price to Sales Ratio | 1.01 |
| Price to Cash Ratio | 0.64 |
| Price to Book Ratio | -0.13 |
| Dividend Yield | - |
| Shares Outstanding | 44.57M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 25.65% |
| 52 Week High | 0.5395 |
| 52 Week Low | 0.16 |
| Spread (Intraday) | 0.08 (27.5%) |
| Company Name | Aridis Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aridispharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
